Short Interest in Biofrontera Inc. (NASDAQ:BFRI) Declines By 50.6%

Biofrontera Inc. (NASDAQ:BFRI) was the target of a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 81,700 shares, a decline of 50.6% from the February 13th total of 165,500 shares. Currently, 1.1% of the shares of the stock are sold short. Based on an average trading volume of 541,300 shares, the days-to-cover ratio is currently 0.2 days.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in BFRI. Virtu Financial LLC bought a new stake in shares of Biofrontera during the fourth quarter worth $48,000. AIGH Capital Management LLC increased its position in Biofrontera by 61.8% during the fourth quarter. AIGH Capital Management LLC now owns 811,097 shares of the company’s stock worth $884,000 after buying an additional 309,663 shares during the last quarter. Finally, Rosalind Advisors Inc. lifted its holdings in Biofrontera by 63.9% during the 4th quarter. Rosalind Advisors Inc. now owns 811,918 shares of the company’s stock valued at $885,000 after purchasing an additional 316,428 shares during the last quarter. 10.08% of the stock is currently owned by institutional investors.

Biofrontera Stock Down 1.5 %

Biofrontera stock traded down $0.01 during mid-day trading on Friday, hitting $0.93. 48,264 shares of the company were exchanged, compared to its average volume of 920,725. Biofrontera has a 1-year low of $0.65 and a 1-year high of $2.43. The business has a fifty day moving average of $1.06 and a 200 day moving average of $1.03. The company has a market capitalization of $7.17 million, a PE ratio of -0.41 and a beta of 0.30.

Biofrontera Company Profile

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.